PMID: 2095572Dec 1, 1990Paper

Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2)

Pharmaceutical Research
M Hu, R T Borchardt

Abstract

The Caco-2 model system (Hidalgo et al., Gastroenterology, 96:736-749, 1989), which is a monolayer of polarized intestinal epithelial cells grown onto a porous polycarbonate membrane, was used to study the mechanism of transcellular transport of an antihypertensive agent, L-alpha-methyldopa (L-alpha-MD). The results showed that the transport of L-alpha-MD was pH, glucose, concentration, and temperature dependent, and it could be inhibited by metabolic inhibitors (e.g., 2,4-dinitrophenol) and by amino acids (e.g., L-phenylalanine) which have an affinity for the large neutral amino acid (LNAA) carrier. In addition, the apparent kinetic constants describing the transcellular transport of L-alpha-MD were altered depending on the time interval between feeding the cells and the transport experiments (postfeeding time, PFT). The apparent maximum carrier flux (Jmax) of L-alpha-MD was significantly increased (from 155 to 547 pmol/mg protein/min) when PFT was prolonged from 8.5 to 56 hr. These results indicated that the transcellular transport of L-alpha-MD through the polarized Caco-2 cell monolayer was carrier mediated via the LNAA carrier. The similarities in the characteristics of L-alpha-MD transport exhibited by the Caco-2 model sy...Continue Reading

Citations

Jan 20, 1998·Drug and Chemical Toxicology·M M Doherty, K S Pang
Jul 1, 1997·The Journal of Pharmacy and Pharmacology·H Lennernäs
Dec 1, 2001·Expert Opinion on Biological Therapy·C YangA K Mitra
Dec 14, 2001·AAPS PharmSci·H K Han, G L Amidon
Jan 1, 1997·Journal of Drug Targeting·L Kupczyk-SubotkowskaR T Borchardt
Dec 4, 2004·Biological & Pharmaceutical Bulletin·Georges Da ViolantePhilippe Arnaud
Mar 1, 1995·Medicinal Research Reviews·K M HillgrenR T Borchardt
Dec 1, 2001·Expert Opinion on Biological Therapy·G S TirucheraiA K Mitra
Mar 7, 2009·Chemical Reviews·Stefan Balaz
Jun 1, 1996·Journal of Pharmaceutical Sciences·M TomitaS Awazu
Apr 21, 1998·Journal of Pharmaceutical Sciences·H Lennernäs
Oct 8, 2005·Pharmacology & Therapeutics·Mikihisa TakanoTeruo Murakami
Jun 2, 2007·Journal of Pharmaceutical Sciences·Donna A Volpe
Aug 8, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Hye-Ryoung KimHo-Chul Shin
Jul 14, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Paulo PaixãoJosé A G Morais
May 4, 2011·Bioorganic & Medicinal Chemistry·Ziad OmranDonald Cairns

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.